The Bill Silverman Prize is awarded to acknowledge explicitly the value of criticism of Cochrane, with a view to helping to improve its work, and thus achieve its aim of helping people make well-informed decisions about health care by providing the best possible evidence on the effects of healthcare interventions. It is awarded every year at the Cochrane Colloquium.
We are seeking someone external to Cochrane, to join the Bill Silverman Prize Committee. Deadline: 30 November.
“Cochrane’s mission is to provide accessible and credible information to support informed decision-making. Therefore, Cochrane values constructive criticism of its work and publicly recognizes this through the Bill Silverman Prize. Such criticisms based on high quality research facilitate improvement or change in Cochrane methods and policy. We look forward to receiving your nominations.”
Yemisi Takwoingi, 2014 Bill Silverman Prize winner
William (Bill) Silverman, MD
William (Bill) Silverman (1924-2004) was one of the founders of American neonatal medicine. He was honoured repeatedly as one of the pioneers in his specialty; however, he often evoked somewhat contradictory responses amongst his colleagues because he was in the habit of raising troubling questions about the scientific basis and ethics of his and their practices. Like many of the people who have helped to establish Cochrane, Bill Silverman could be regarded as a 'troublemaker'. As he reiterated frequently, however, criticism is a form of troublemaking that can help to drive progress. Furthermore, criticism should not be limited to examining the work of others, but should also include self-criticism.
Bill Silverman Prize
The Bill Silverman Prize is offered annually and explicitly acknowledges Cochrane's value of criticism, with a view to helping to improve its work, and thus achieve its aim of helping people make well-informed decisions about health care by providing the best possible evidence on the effects of healthcare interventions. The Cochrane Steering Group approved the establishment of the Prize in 2007, and it was awarded for the first time in 2008.
The prize is for a published paper which demonstrates originality and critical thinking, either in evaluating any aspect of the preparation, maintenance or dissemination of Cochrane Reviews or about the work of Cochrane more generally. It should be of high quality, have been accompanied by constructive suggestions on how the relevant aspects of Cochrane’s work could be improved; and have had, or is likely to have, a positive impact on the scientific quality, relevance and use of Cochrane Reviews.
The Prize is awarded to the corresponding author of the selected publication, and comprises a cash award of USD $1000 and a certificate. It is this person’s responsibility to distribute the cash award in a fair way to co-authors of the paper.
The Prize Committee comprises five members, at least two of whom do not have an active role within any Cochrane Group (other than, possibly, as an author or referee of one or more Cochrane Reviews). The other members are the most recent winners of the Prize. Members of the Committee for 2018 are and Jamie Kirkham (2015 winner, Co-Chair), Rodolfo Saracci (external, Co-Chair), Michelle Roseman (2013 winner), and David Henry (2017 winner).
Could you be our next external committee member?
Contact Jamie Kirkham at J.J.Kirkham@liverpool.ac.uk, if you are interested in joining the committee.
Deadline: 30 November
· No active role within any Cochrane Group (other than, possibly, as an author or referee of one or more Cochrane Reviews)
· Available between June – August 2018 to review prize nominations